26.80DKK+1.52%Mkt Cap: 1.66B $P/E: 20.151d ago
Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through three segments: Prosthetics and Neu…
Indicators:|
Key Statistics
Company
Market Cap1.66B $
Enterprise Value1.74B $
Revenue (TTM)139.58M $
Gross Profit84.27M $
Net Income (TTM)12.14M $
Revenue/Share0.3286 USD
Last Price26.80 DKK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees4.5K
CountryDK
SectorHealthcare
IndustryMedical Devices
ISINIS0000000040
Valuation
P/E (Trailing)20.15
P/E (Forward)15.66
PEG—
EV/EBITDA79.29
EV/Revenue12.43
P/S11.91
P/B1.94
EPS (TTM)1.33
EPS (Forward)1.71
52W Range
25.0014% of range37.90
52W High37.90 DKK
52W Low25.00 DKK
Profitability
Gross Margin62.30%
Oper. Margin9.74%
EBITDA Margin15.68%
Profit Margin8.97%
ROE9.36%
ROA4.82%
Growth
Revenue Growth14.60%
Earnings Growth21.40%
Cash Flow & Leverage
Operating CF19.32M $
CapEx (TTM)4.71M $
FCF Margin7.69%
FCF Yield0.65%
Net Debt66.90M $
Net Debt/EBITDA3.06
Balance Sheet
Debt/Equity0.61
Current Ratio1.21
Quick Ratio0.63
Book Value/Sh13.82 DKK
Cash/Share0.2190 DKK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 DKK
Div. Yield—
5Y Avg Yield0.39%
Payout Ratio0.00%
Ex-Div DateMar 13, 2020
Pay Date—
Analyst Consensus
Rating—
Target (Mean)33.30 DKK
Upside (mean)+24.3%
Target Range29.00 DKK – 40.00 DKK
DKK29.00+24.3% to meanDKK40.00
# Analysts5
Ownership
Shares Out.426.02M
Float157.31M
Insiders12.41%
Institutions80.05%
Technical
SMA 5026.92 (-0.4%)
SMA 20030.43 (-11.9%)
Beta0.46
S&P 52W Chg20.05%
Avg Vol (30d)92.34K
Avg Vol (10d)64.03K
Technical Indicators
RSI (14)51.6
MACD-0.1689
MACD Signal-0.1691
MACD Hist.+0.0002
BB Upper27.52 DKK
BB Middle26.70 DKK
BB Lower25.89 DKK
BB Width6.13%
ATR (14)0.6351 DKK
Vol Ratio (20d)0.96x